Showing results (1-10 of 128) with videos related to
Sort By:
Pageof 13
Journal of the American Heart Association|November 1, 2021
Admission Glucose Levels and Associated Risk for Heart Failure After Myocardial Infarction in Patients Without DiabetesViveca Ritsinger, Emil Hagström, Bo Lagerqvist, et al.The Canadian Journal of Cardiology|December 25, 2025
Cardiac Rehabilitation Registries as Tools for Quality Improvement and Research: Insights From the SWEDEHEART-CR registryMaria Bäck, Margret Leosdottir, Stefan James, et al.Lakartidningen|March 20, 2026
[Lipoprotein(a) - the hereditary risk factor for cardiovascular disease]Elias Björnson, Jonas Brinck, Emil Hagström, et al.Journal of the American Heart Association|February 19, 2020
Temporal Trends in the Prevalence of Cancer and Its Impact on Outcome in Patients With First Myocardial Infarction: A Nationwide StudyMatthijs A Velders, Emil Hagström, Stefan K JamesEuropean Journal of Endocrinology|June 24, 2006
Metabolic abnormalities in patients with normocalcemic hyperparathyroidism detected at a population-based screeningEmil Hagström, Ewa Lundgren, Jonas Rastad, et al.Upsala Journal of Medical Sciences|May 11, 2018
Treatment target re-classification of subjects comparing estimation of low-density lipoprotein cholesterol by the Friedewald equation and direct measurement of LDL-cholesterolAnders Larsson, Emil Hagström, Lennart Nilsson, et al.BMC Cardiovascular Disorders|August 18, 2017
Predicted impact of lipid lowering therapy on cardiovascular and economic outcomes of Swedish atherosclerotic cardiovascular disease guidelineGunilla Journath, Kristina Hambraeus, Emil Hagström, et al.Heart (British Cardiac Society)|September 10, 2016
Discovery of new biomarkers for atrial fibrillation using a custom-made proteomics chipLars Lind, Johan Sundström, Markus Stenemo, et al.European Journal of Preventive Cardiology|February 19, 2026
Triglyceride reduction after MI and major adverse outcomes in SWEDEHEART-insights for future trialsJessica Schubert, Emil Hagström, Johan Westerbergh, et al.Diabetes & Vascular Disease Research|November 24, 2020
Diabetes, metformin and glucose lowering therapies after myocardial infarction: Insights from the SWEDEHEART registryViveca Ritsinger, Bo Lagerqvist, Pia Lundman, et al.Pageof 13